Diagnóstica Longwood
1 known investors
Find your way into Diagnóstica Longwood
Sign up to find every way you can get introduced to Diagnóstica Longwood
- Your email: who you already know at Diagnóstica Longwood, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Diagnóstica Longwood team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Diagnóstica Longwood is a distributor of in vitro diagnostics technologies, supplying NGS-based assays, kits and reagents for molecular diagnostics in areas such as oncology, hereditary and rare diseases, and microbiology. Founded in 1992, it serves clinical and research laboratories with technical support and its own inventory in Spain.
Investors · 1
Apheonlisted by Apheon
How we know: Apheon's portfolio page · Not right? Tell us
Frequently asked questions
- What does Diagnóstica Longwood do?
- Diagnóstica Longwood is a distributor of in vitro diagnostics technologies, supplying NGS-based assays, kits and reagents for molecular diagnostics in areas such as oncology, hereditary and rare diseases, and microbiology. Founded in 1992, it serves clinical and research laboratories with technical support and its own inventory in Spain.
- Who are Diagnóstica Longwood's investors?
- Diagnóstica Longwood's investors include Apheon.
